Colin Widen is a seasoned executive and thought leader in the institutional asset management and life sciences advisory sectors, bringing over 25 years of expertise in managing investments, raising capital, and guiding innovative financial strategies. As Managing Member of Eden Roc Advisors since 2018, Colin has dedicated his efforts to healthcare advisory and consulting with a focus on capital formation and structuring in areas such as Health Care IT (HCIT) and Diagnostics. His insights and strategic approach have solidified his reputation as a trusted partner in the Greater Boston area and beyond.

Throughout his career, Colin has consistently demonstrated an ability to navigate the evolving landscape of asset management. He has a proven track record of working with Family Offices, a dynamic and growing segment of the investment ecosystem that now represents more capital than traditional private equity and venture capital. Recognizing the need for investment managers to adapt their portfolio strategies and allocation techniques, Colin has been a vocal advocate for challenging conventional viewpoints and embracing tactical innovation.

In addition to his leadership at Eden Roc Advisors, Colin serves as a Client Development specialist with 1908 Advisors, where he provides fiduciary-focused advisors with differentiated value propositions that enhance financial planning and foster ethical investment practices. His work with 1908 Advisors reflects his passion for empowering others to achieve success through doing what is right, a philosophy that has guided his professional endeavors.

Colin’s entrepreneurial spirit was evident during his tenure as CEO of Boston Innovation Capital from 2014 to 2018. In this role, he raised capital for emerging life sciences companies, introducing them to institutional investors and Family Offices worldwide. He played a pivotal role in guiding CEOs through the complexities of capital raising, leveraging his deep industry knowledge to build meaningful connections between investors and visionary management teams.

Earlier in his career, Colin founded Parker Point Capital, LLC, a boutique broker-dealer that raised over $1 billion for hedge funds and private equity funds. His hands-on approach included evaluating marketing strategies, creating compelling collateral, and targeting Family Offices and institutional investors globally. At Deutsche Bank, where he served as Director, Colin provided consultative services to Family Offices, endowments, and foundations, specializing in hedge fund portfolios and tax optimization strategies.

Colin’s academic foundation in Economics from Amherst College complements his professional achievements, providing him with the analytical rigor to succeed in a competitive industry.

A relentless innovator, Colin continues to drive meaningful impact by bridging the gap between investors and emerging opportunities. His commitment to advancing the intersection of life sciences and asset management positions him as a key figure in shaping the future of these industries.

• Character: Colin Widen demonstrates integrity and a commitment to ethical practices, consistently fostering trust with clients and investors.
• Knowledge: He possesses deep expertise in asset management, life sciences, and capital formation, gained through over 25 years of diverse industry experience.
• Strategic: Colin excels at identifying growth opportunities and aligning innovative financial strategies with evolving market demands.
• Communication: He is an effective communicator, building strong relationships and bridging investors with emerging opportunities through clear, compelling dialogue.